ROBERT HAGEMANN - 31 Mar 2024 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: Director
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Robert A. Hagemann (power of attorney previously filed)
Issuer symbol: ZBH
Transactions as of: 31 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 02 Apr 2024, 17:21:33 UTC
Previous filing: 03 Jan 2024
Next filing: 07 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Phantom Stock Units	Award	$0	+254	+0.93%	$0.000000	27,496	31 Mar 2024	Common Stock	254	$132.75	Direct	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2	The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3	Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4	Includes 51.369 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.